COPS5, which has deubiquitination activity attributed to the inactivation of cullin‐RING E3 ligases through deneddylation,[14] has been implicated in tumor progression and therapeutic resistance.[15, 16, 17] Therefore, we focused on COPS5 in the subsequent studies. This evidence concerns the gene COPS5 and neoplasm.